FunPep - Crunchbase Company Profile & Funding

Q: Where is FunPep's headquarters?

FunPep is located in Tokyo, Tokyo, Japan.

Q: Who invested in FunPep?

FunPep has 25 investors including Growth Capital And SBI Investment.

Q: When was the last funding round for FunPep?

FunPep closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

FunPep

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About FunPep

CB Rank

38847

FunPep is a biotechnology firm that develops functional cosmetics, medical supplies, and pharmaceutical drugs for people's well-being.

Founded

obfuscation

Private

Venture - Series Unknown

Tokyo, Tokyo, Japan

11-50

funpep.co.jp

Biotechnology

Medical Device

mHealth

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Hideki Tomioka: Director of Research and Development Dept. and CSO,Clinical Development
Motoji Horiguchi: Outside Corporate Auditors

Details

Legal Name

FunPep Co., Ltd.

Also Known As

ファンペップ

Operating Status

Active

Company Type

For Profit

Founders

Matsuda Shuuichi

About the Company

FunPep engages in the research and development of pharmaceuticals, cosmetics, and medical devices based on functional peptides. They produces intractable ulcer treatment drugs, antibody drugs, pharmaceutical drugs, and other products. The goal of FunPep is to replace antibody medicines with next-generation pharmaceutical products, specifically

antibody-inducing peptide.

Phone Number

+81 36-721-1237

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Antibody Inducing Peptides

Functional peptides designed to induce the body to produce antibodies targeting disease-related proteins, enabling long-lasting therapeutic effects with infrequent dosing.

FPP004X (Antibody Inducing Peptide targeting IgE)

A peptide drug candidate that induces antibodies against IgE to provide sustained therapeutic effects for allergic diseases such as hay fever.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - FunPep	1	obfuscated obfuscation	Growth Capital	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Growth Capital	Yes	Venture Round - FunPep	—
Growth Capital	Yes	Venture Round - FunPep	—
Growth Capital	Yes	Venture Round - FunPep	—
Growth Capital	Yes	Venture Round - FunPep	—
Growth Capital	Yes	Venture Round - FunPep	—

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Board Members and Advisors

Employee Profiles

Hideki Tomioka Director of Research and Development Dept. and CSO,Clinical Development
Motoji Horiguchi Outside Corporate Auditors
Toshimi Miyoshi President and Representative Director
Minami Naruhito Outside Corporate Auditors